XTL Biopharmaceuticals Ltd ADR
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $289 | $289 | $162 | $0 |
Gross Profit | -43 | -43 | 162 | |
EBITDA | -479 | -460 | -691 | |
EBIT | -764 | -421 | ||
Net Income | -255 | -255 | -553 | -704 |
Net Change In Cash | 289 | 289 | 162 | 0 |
Cash | 371 | 371 | 820 | 594 |
Basic Shares | 5,449 | 881,385 | 5,449 | 5,449 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $451 | $0 | $-459 | $1,466 |
Gross Profit | 3 | 0 | -460 | 1,465 |
EBITDA | -930 | -764 | -879 | -1,030 |
EBIT | -1,129 | -765 | -880 | -1,031 |
Net Income | -1,027 | -1 | -1,348 | 435 |
Net Change In Cash | 451 | 0 | -459 | 1,466 |
Free Cash Flow | -1,672 | -707 | -901 | -1,049 |
Cash | 371 | 1,401 | 2,094 | 2,969 |
Basic Shares | 7,041 | 5,449 | 5,449 | 6,155 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | $0 |
2024-12-31 | -$0.02 |
2024-09-30 | -$0.04 |
2024-06-30 | -$0.12 |
